NO905008L - Fremgangsmaate for fremstilling av heterocykliske forbindelser. - Google Patents

Fremgangsmaate for fremstilling av heterocykliske forbindelser.

Info

Publication number
NO905008L
NO905008L NO90905008A NO905008A NO905008L NO 905008 L NO905008 L NO 905008L NO 90905008 A NO90905008 A NO 90905008A NO 905008 A NO905008 A NO 905008A NO 905008 L NO905008 L NO 905008L
Authority
NO
Norway
Prior art keywords
procedure
preparation
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
NO90905008A
Other languages
English (en)
Other versions
NO905008D0 (no
Inventor
Claude Gueremy
Jean-Luc Malleron
Serge Mignani
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8915177A external-priority patent/FR2654729B1/fr
Priority claimed from FR8917164A external-priority patent/FR2656306A1/fr
Priority claimed from FR9007774A external-priority patent/FR2663635A2/fr
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO905008D0 publication Critical patent/NO905008D0/no
Publication of NO905008L publication Critical patent/NO905008L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
NO90905008A 1989-11-20 1990-11-19 Fremgangsmaate for fremstilling av heterocykliske forbindelser. NO905008L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8915177A FR2654729B1 (fr) 1989-11-20 1989-11-20 Derives de la piperidine, leur preparation et les medicaments les contenant.
FR8917164A FR2656306A1 (fr) 1989-12-26 1989-12-26 Derives heterocycliques, leur preparation et les medicaments les contenant.
FR9007774A FR2663635A2 (fr) 1989-12-26 1990-06-21 Derives heterocycliques, leur preparation et les medicaments les contenant.

Publications (2)

Publication Number Publication Date
NO905008D0 NO905008D0 (no) 1990-11-19
NO905008L true NO905008L (no) 1991-05-21

Family

ID=27252056

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90905008A NO905008L (no) 1989-11-20 1990-11-19 Fremgangsmaate for fremstilling av heterocykliske forbindelser.

Country Status (13)

Country Link
US (1) US5114949A (no)
EP (1) EP0429341A3 (no)
JP (1) JPH03190858A (no)
AU (1) AU624280B2 (no)
CA (1) CA2030238A1 (no)
FI (1) FI905700A (no)
HU (1) HUT59389A (no)
IE (1) IE904165A1 (no)
IL (1) IL96405A0 (no)
NO (1) NO905008L (no)
PL (1) PL287845A1 (no)
PT (1) PT95938A (no)
YU (1) YU247190A (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2664592B1 (fr) * 1990-07-10 1994-09-02 Adir Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2675800A1 (fr) * 1991-04-26 1992-10-30 Rhone Poulenc Rorer Sa Derives heterocycliques antiserotonines leur preparation et les medicaments les contenant.
DE4120322A1 (de) * 1991-06-20 1992-12-24 Bayer Ag Aminomethyl-substituierte 2,3-dihydropyrano(2,3-b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
FR2678935A1 (fr) * 1991-07-11 1993-01-15 Rhone Poulenc Rorer Sa Procede de preparation du dihydro-5,6 1h,4h-1,2,5-thiadiazolo[4,3,2-ij] quinoleine dioxyde-2,2 et intermediaires.
US6034078A (en) * 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
IT1271352B (it) * 1993-04-08 1997-05-27 Boehringer Ingelheim Italia Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
GB9416571D0 (en) * 1994-08-16 1994-10-12 Battelle Memorial Institute Novel alkylamino derivatives as sigma 2 selective ligands
US5756725A (en) * 1996-04-24 1998-05-26 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
EA001296B1 (ru) * 1996-04-24 2000-12-25 Мерк Энд Ко., Инк. Антибактериальные соединения карбапенема, содержащие их фармацевтические композиции и способы лечения
GB9613423D0 (en) * 1996-06-26 1996-08-28 Lilly Industries Ltd Pharmaceutical compounds
JP4076234B2 (ja) * 1996-06-28 2008-04-16 明治製菓株式会社 テトラヒドロベンズインドール化合物
BR9714432A (pt) * 1996-12-23 2000-05-02 Hoeschst Marion Roussel Inc Derivados de 3-aril-2-(1-substituìdo-4-piperidinil)-1(1-di(oxo-3h-bezo [d]-isoatiazol, sua preparação e seu uso como moduladores de função neurotransmissora
US5994343A (en) * 1997-10-02 1999-11-30 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6562850B1 (en) * 1998-07-17 2003-05-13 The University Of Tennessee Research Corporation Methods of synthesizing sultams and anti-viral compositions
WO2000021963A1 (en) * 1998-10-13 2000-04-20 Smithkline Beecham Corporation Il-8 receptor antagonists
US6440993B1 (en) * 1999-10-12 2002-08-27 Smithkline Beecham Corporation IL-8 receptor antagonists
GB0013060D0 (en) 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
WO2002048105A2 (en) 2000-11-16 2002-06-20 Wyeth Aryloxy piperidinyl derivatives for the treatment of depression
AU2002235250A1 (en) 2000-11-17 2002-05-27 Wyeth Aryloxy piperidinyl indoles for treating depression
GB0117899D0 (en) 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds
US8233978B1 (en) * 2004-07-12 2012-07-31 Pacesetter, Inc. Method and device for switching between arrhythmia prevention modes
EP3019498B1 (en) * 2013-07-12 2018-12-26 Council Of Scientific & Industrial Research Novel tricyclic compounds and process for preparation thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399608A (en) * 1971-11-19 1975-07-02 Wyeth John & Brother Ltd Process for preparing indole derivatives
DE2708913A1 (de) * 1976-03-04 1977-09-08 Hoechst Ag Benzoylpiperidyalkyl-indole und verwandte verbindungen
US4110449A (en) * 1977-05-23 1978-08-29 E. R. Squibb & Sons, Inc. 2-substituted benzisothiazol-3-ones
DE3028198A1 (de) * 1980-07-25 1982-02-25 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von piperidinyl-alkyl-indolen
FR2506311A1 (fr) * 1981-05-22 1982-11-26 Pharmindustrie ((piperidyl-4)-2 alkyl-1 ethyl)-3 indoles et leur utilisation comme medicaments
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
DE3717561A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
JPS63301881A (ja) * 1987-06-01 1988-12-08 Fujisawa Pharmaceut Co Ltd インドリルピペリジン誘導体
FR2621588B1 (fr) * 1987-10-08 1991-05-24 Roussel Uclaf Nouveaux derives de la 1,1-dioxo 1,2-benzoisothiazol 3-one, leur procede de preparation et leur application comme medicaments
FR2628425B1 (fr) * 1988-03-08 1992-04-03 Rhone Poulenc Sante Derives d'isoindolinone, leurs procedes de preparation et les medicaments les contenant
IL90858A (en) * 1988-07-07 1994-08-26 Rhone Poulenc Sante History (Aza) Naftalensultam, their preparation and preparations containing them

Also Published As

Publication number Publication date
PT95938A (pt) 1991-09-30
HUT59389A (en) 1992-05-28
AU6675490A (en) 1991-06-20
AU624280B2 (en) 1992-06-04
IE904165A1 (en) 1991-05-22
HU907200D0 (en) 1991-05-28
FI905700A (fi) 1991-05-21
YU247190A (sh) 1992-09-07
CA2030238A1 (fr) 1991-05-21
JPH03190858A (ja) 1991-08-20
PL287845A1 (en) 1992-02-24
EP0429341A2 (fr) 1991-05-29
US5114949A (en) 1992-05-19
EP0429341A3 (en) 1991-11-13
IL96405A0 (en) 1991-08-16
NO905008D0 (no) 1990-11-19
FI905700A0 (fi) 1990-11-19

Similar Documents

Publication Publication Date Title
NO905255L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte acylaminotiazoler.
NO900830L (no) Fremgangsmaate for fremstilling av piperidinforbindelser.
NO904987L (no) Fremgangsmaate for fremstilling av indolderivater.
NO912411D0 (no) Fremgangsmaate for fremstilling av bicykliske heterocykliske forbindelser.
NO905008D0 (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
NO902003D0 (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO901554D0 (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO903431L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO904285L (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO903275L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO892204D0 (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
NO905377L (no) Fremgangsmaate for fremstilling av glycerolderivater.
NO903043D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903207D0 (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO901690D0 (no) Fremgangsmaate til fremstilling av substituerte azetidinylisotiazolpyridon-derivater.
NO913692D0 (no) Fremgangsmaate for fremstilling av karbapenemforbindelser.
NO903666D0 (no) Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO901067L (no) Fremgangsmaate for fremstilling av tiofener.
NO904535L (no) Fremgangsmaate for fremstilling av fenoksy-heterocykliske forbindelser.
NO904060D0 (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO905047L (no) Fremgangsmaate for fremstilling av selenofenderivater.
NO904362D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO913089D0 (no) Fremgangsmaate for fremstilling av tetrazolforbindelser.